130 related articles for article (PubMed ID: 24842634)
1. Whither pharmacometrics?: present state and future choices.
Vicini P; Smith BP
Clin Pharmacol Ther; 2014 Jun; 95(6):567-71. PubMed ID: 24842634
[TBL] [Abstract][Full Text] [Related]
2. The ISoP Standards and Best Practices Committee.
Bruno R; Mentré F; Tannenbaum S; Wang Y; Corrigan B; Mager DE
Clin Pharmacol Ther; 2014 Jun; 95(6):581-2. PubMed ID: 24842638
[TBL] [Abstract][Full Text] [Related]
3. Advancing pharmacometrics and systems pharmacology.
Waldman SA; Terzic A
Clin Pharmacol Ther; 2012 Nov; 92(5):535-7. PubMed ID: 23085873
[TBL] [Abstract][Full Text] [Related]
4. Pharmacometric Modeling and Simulation Is Essential to Pediatric Clinical Pharmacology.
Neely M; Bayard D; Desai A; Kovanda L; Edginton A
J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S73-S85. PubMed ID: 30248199
[TBL] [Abstract][Full Text] [Related]
5. Pharmacometrics and the transition to model-based development.
Grasela TH; Dement CW; Kolterman OG; Fineman MS; Grasela DM; Honig P; Antal EJ; Bjornsson TD; Loh E
Clin Pharmacol Ther; 2007 Aug; 82(2):137-42. PubMed ID: 17632539
[TBL] [Abstract][Full Text] [Related]
6. Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applications.
Bhattaram VA; Booth BP; Ramchandani RP; Beasley BN; Wang Y; Tandon V; Duan JZ; Baweja RK; Marroum PJ; Uppoor RS; Rahman NA; Sahajwalla CG; Powell JR; Mehta MU; Gobburu JV
AAPS J; 2005 Oct; 7(3):E503-12. PubMed ID: 16353928
[TBL] [Abstract][Full Text] [Related]
7. ASCPT Task Force for advancing pharmacometrics and integration into drug development.
Goldberger MJ; Singh N; Allerheiligen S; Gobburu JV; Lalonde R; Smith B; Ryder S; Yozviak A
Clin Pharmacol Ther; 2010 Aug; 88(2):158-61. PubMed ID: 20648032
[TBL] [Abstract][Full Text] [Related]
8. Time for quantitative clinical pharmacology: a proposal for a pharmacometrics curriculum.
Holford N; Karlsson MO
Clin Pharmacol Ther; 2007 Jul; 82(1):103-5. PubMed ID: 17495873
[TBL] [Abstract][Full Text] [Related]
9. Pharmacometrics 2020.
Gobburu JV
J Clin Pharmacol; 2010 Sep; 50(9 Suppl):151S-157S. PubMed ID: 20881229
[TBL] [Abstract][Full Text] [Related]
10. Should pharmacometrics be training the next R&D president?
Gobburu JV
Clin Pharmacol Ther; 2014 Jun; 95(6):579-80. PubMed ID: 24842637
[TBL] [Abstract][Full Text] [Related]
11. The future of pharmacology in the 20th century: a 19th century prediction.
Burks TF
Proc West Pharmacol Soc; 1999; 42():161-3. PubMed ID: 10697715
[No Abstract] [Full Text] [Related]
12. CPT: Pharmacometrics and Systems Pharmacology.
van der Graaf PH
CPT Pharmacometrics Syst Pharmacol; 2012 Sep; 1(9):e8. PubMed ID: 23835888
[TBL] [Abstract][Full Text] [Related]
13. A strategic view on the use of pharmacodynamic biomarkers in early clinical drug development.
Severino ME; Dubose RF; Patterson SD
IDrugs; 2006 Dec; 9(12):849-53. PubMed ID: 17139572
[TBL] [Abstract][Full Text] [Related]
14. Integration of biostatistics and pharmacometrics computing platforms for efficient and reproducible PK/PD analysis: a case study.
Ou YC; Lo A; Lee B; Liu P; Kimura K; Eary C; Hopkins A
J Clin Pharmacol; 2013 Nov; 53(11):1112-20. PubMed ID: 23913679
[TBL] [Abstract][Full Text] [Related]
15. The model veterinary drug code--what could it mean?
McKean JD
J Am Vet Med Assoc; 1988 Apr; 192(7):885-90. PubMed ID: 3366674
[No Abstract] [Full Text] [Related]
16. Pharmacometrics: The Already-Present Future of Precision Pharmacology.
Bandeira LC; Pinto L; Carneiro CM
Ther Innov Regul Sci; 2023 Jan; 57(1):57-69. PubMed ID: 35984633
[TBL] [Abstract][Full Text] [Related]
17. The future of veterinary therapeutics: a glimpse towards 2030.
Riviere JE
Vet J; 2007 Nov; 174(3):462-71. PubMed ID: 17825591
[TBL] [Abstract][Full Text] [Related]
18. Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions.
Zhao P; Rowland M; Huang SM
Clin Pharmacol Ther; 2012 Jul; 92(1):17-20. PubMed ID: 22713733
[TBL] [Abstract][Full Text] [Related]
19. Iberoamerican Pharmacometrics Network Congress 2018 Report: Fostering Modeling and Simulation Approaches for Drug Development and Regulatory and Clinical Applications in Latin America.
Ibarra M; Dalla Costa T; Schaiquevich P; Cristofoletti R; Hernández González I; Fajardo-Robledo NS; Aragón Novoa M; Pecchio M; Cortinez I; Trocóniz IF; Romero-Tejeda EM
CPT Pharmacometrics Syst Pharmacol; 2019 Apr; 8(4):197-200. PubMed ID: 30681295
[No Abstract] [Full Text] [Related]
20. [New approaches in pharmacology: numerical modelling and simulation].
Boissel JP; Cucherat M; Nony P; Dronne MA; Kassaï B; Chabaud S
Therapie; 2005; 60(1):1-15. PubMed ID: 15929468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
